Semaglutide may reduce smoking risks for diabetes patients

FHS
July 29, 2024
9:01 pm

Semaglutide shows promise in reducing tobacco use disorder-related health encounters in patients with type 2 diabetes, but further clinical trials are needed to confirm its efficacy.

Why health systems are faring better so far in 2024

Americans, especially Medicare beneficiaries, are getting more medical care these days. Demand from aging Baby Boomers is keeping people in doctor’s offices, and health care

May 20, 2024

Graphene biosensor offers accurate assessment of meat freshness

The freshness of animal meat is an essential property determining its quality and safety. With advanced technology capable of preserving food for extended periods of

February 20, 2024

Lessons for scientists from the All of Us Research Program backlash

Scientists are taught early in our training that criticism is a fundamental part of the job. What we are not usually trained to navigate, however,

March 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.